KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Non-Current Assets (2016 - 2025)

Idexx Laboratories has reported Non-Current Assets over the past 17 years, most recently at $1.9 billion for Q4 2025.

  • Quarterly results put Non-Current Assets at $1.9 billion for Q4 2025, up 2.29% from a year ago — trailing twelve months through Dec 2025 was $1.9 billion (up 2.29% YoY), and the annual figure for FY2025 was $1.9 billion, up 2.29%.
  • Non-Current Assets for Q4 2025 was $1.9 billion at Idexx Laboratories, up from $1.9 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for IDXX hit a ceiling of $2.0 billion in Q2 2025 and a floor of $1.2 billion in Q1 2021.
  • Median Non-Current Assets over the past 5 years was $1.7 billion (2023), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Non-Current Assets: rose 22.82% in 2021 and later fell 0.38% in 2025.
  • Idexx Laboratories' Non-Current Assets stood at $1.5 billion in 2021, then grew by 11.05% to $1.6 billion in 2022, then increased by 7.26% to $1.8 billion in 2023, then increased by 7.3% to $1.9 billion in 2024, then increased by 2.29% to $1.9 billion in 2025.
  • The last three reported values for Non-Current Assets were $1.9 billion (Q4 2025), $1.9 billion (Q3 2025), and $2.0 billion (Q2 2025) per Business Quant data.